Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Sylvie Seeuws is active.

Publication


Featured researches published by Sylvie Seeuws.


Arthritis & Rheumatism | 2010

Invariant natural killer T cells are natural regulators of murine spondylarthritis

Peggy Jacques; Koen Venken; Katrien Van Beneden; Hamida Hammad; Sylvie Seeuws; Michael Drennan; Dieter Deforce; Gust Verbruggen; Maria Apostolaki; George Kollias; Bart N. Lambrecht; Martine De Vos; Dirk Elewaut

OBJECTIVE To investigate the role of invariant natural killer T (iNKT) cells in TNF(DeltaARE/+) mice, an animal model of spondylarthritis (SpA) with both gut and joint inflammation. METHODS The frequency and activation of iNKT cells were analyzed on mononuclear cells from the lymph nodes and livers of mice, using flow cytometry with alpha-galactosylceramide/CD1d tetramers and quantitative polymerase chain reaction for the invariant V(alpha)14-J(alpha)18 rearrangement. Bone marrow-derived dendritic cells (DCs) were obtained by expansion of primary cells with granulocyte-macrophage colony-stimulating factor followed by coculture with iNKT cell hybridomas, and interleukin-2 release into the cocultures was then measured by enzyme-linked immunosorbent assay (ELISA). Cytokine levels were determined by ELISA or cytometric bead array analyses of freshly isolated DCs and iNKT cells in mixed cocultures. TNF(DeltaARE/+) mice were backcrossed onto J(alpha)18(-/-) and CD1d(-/-) mice, and disease onset was evaluated by clinical scoring, positron emission tomography, and histology. CD1d levels were analyzed on mononuclear cells in paired blood and synovial fluid samples from patients with SpA compared with healthy control subjects. RESULTS In the absence of iNKT cells, symptoms of gut and joint inflammation in TNF(DeltaARE/+)mice were aggravated. Invariant NKT cells were activated during the course of the disease. This was linked to an enrichment of inflammatory DCs, characterized by high levels of CD1d, particularly at draining sites of inflammation. A similar increase in CD1d levels was observed on DCs from patients with SpA. Inflammatory DCs from TNF(DeltaARE/+) mice stimulated iNKT cells to produce immunomodulatory cytokines, in the absence of exogenous stimulation. Prolonged, continuous exposure, but not short-term exposure, to tumor necrosis factor (TNF) was found to be responsible for the enhanced DC-NKT cell crosstalk. CONCLUSION This mode of iNKT cell activation represents a natural counterregulatory mechanism for the dampening of TNF-driven inflammation.


Journal of Immunology | 2009

Cutting edge: the chemokine receptor CXCR3 retains invariant NK T cells in the thymus.

Michael Drennan; Ann-Sophie Franki; Pieter Dewint; Katrien Van Beneden; Sylvie Seeuws; Serge A. van de Pavert; Emma Reilly; Gust Verbruggen; Thomas E. Lane; Reina E. Mebius; Dieter Deforce; Dirk Elewaut

The current model used to define T cell export from the thymus suggests that emigrating lymphocytes seed the peripheral organs as functionally mature cells. This model holds true for the majority of T cells exported from the thymus with the exception of invariant NK T (iNKT) cells. iNKT cells undergo lineage expansion after positive selection and acquire NK receptor expression once fully mature; yet, the majority of mature iNKT cells are retained in the thymus by an as of yet unidentified mechanism. In this study we demonstrate that mature iNKT cells are retained in the thymus by the chemokine receptor CXCR3. We propose that the expression of CXCR3 ligands in the thymic medullary epithelium promotes the chemotactic retention of mature iNKT thymocytes and prevents leakage of iNKT cells into the peripheral circulation.


Journal of Hepatology | 2014

A bidirectional crosstalk between iNKT cells and adipocytes mediated by leptin modulates susceptibility for T cell mediated hepatitis

Koen Venken; Sylvie Seeuws; Lennart Zabeau; Peggy Jacques; Tine Decruy; Julie Coudenys; Eveline Verheugen; Fien Windels; Dominiek Catteeuw; Michael Drennan; Serge Van Calenbergh; Bart N. Lambrecht; Akihiko Yoshimura; Jan Tavernier; Dirk Elewaut

BACKGROUND & AIMS Immunometabolism is an emerging field of clinical investigation due to the obesity epidemic worldwide. A reciprocal involvement of immune mediators in the body energy metabolism has been recognized for years, but is only partially understood. We hypothesized that the adipokine leptin could provide an important modulator of iNKT cells. METHODS The expression of leptin receptor (LR) on resting and activated iNKT cells was measured by flow cytometry. FACS-sorted hepatic iNKT cells were stimulated with anti-CD3/CD28Ab coated beads in the absence or presence of a neutralizing anti-leptin Ab. Furthermore, we evaluated the outcome of LR blocking nanobody treatment in ConA induced hepatitis and towards metabolic parameters in WT and iNKT cell deficient mice. RESULTS The LR is expressed on iNKT cells and leptin suppresses iNKT cell proliferation and cytokine production in vitro. LR deficient iNKT cells are hyper-responsive further enforcing the role of leptin as an important inhibitor of iNKT cell function. Consistently, in vivo blockade of LR signaling exacerbated ConA hepatitis in wild-type but not in iNKT cell deficient mice, through both Janus kinase (JAK)2 and mitogen-activated protein kinase (MAPK) dependent mechanisms. Moreover, LR inhibition altered fat pad features and was accompanied by insulin resistance, only in wild-type mice. Curiously, this interaction was strictly dependent on MAPK mediated LR signaling in iNKT cells and uncoupled from the more central effects of leptin. CONCLUSIONS Our data support a new concept of immune regulation by which leptin protects towards T cell mediated hepatitis via modulation of iNKT cells.


Cellular and Molecular Life Sciences | 2015

Leptin's metabolic and immune functions can be uncoupled at the ligand/receptor interaction level

Lennart Zabeau; Cathy J. Jensen; Sylvie Seeuws; Koen Venken; Annick Verhee; Dominiek Catteeuw; Geert van Loo; Hui Chen; Ken Walder; Jacob Harvey Hollis; Simon J. Foote; Margaret J. Morris; José Van der Heyden; Frank Peelman; Brian J. Oldfield; Justin P. Rubio; Dirk Elewaut; Jan Tavernier

The adipocyte-derived cytokine leptin acts as a metabolic switch, connecting the body’s metabolism to high-energy consuming processes such as reproduction and immune responses. We here provide genetic and biochemical evidence that the metabolic and immune functions of leptin can be uncoupled at the receptor level. First, homozygous mutant fatt/fatt mice carry a spontaneous splice mutation causing deletion of the leptin receptor (LR) immunoglobulin-like domain (IGD) in all LR isoforms. These mice are hyperphagic and morbidly obese, but display only minimal changes in size and cellularity of the thymus, and cellular immune responses are unaffected. These animals also displayed liver damage in response to concavalin A comparable to wild-type and heterozygous littermates. Second, treatment of healthy mice with a neutralizing nanobody targeting IGD induced weight gain and hyperinsulinaemia, but completely failed to block development of experimentally induced autoimmune diseases. These data indicate that leptin receptor deficiency or antagonism profoundly affects metabolism, with little concomitant effects on immune functions.


Annals of the Rheumatic Diseases | 2010

A multiparameter approach to monitor disease activity in collagen-induced arthritis

Sylvie Seeuws; Peggy Jacques; Jens Van Praet; Michael Drennan; Julie Coudenys; Tine Decruy; Ellen Deschepper; Liên Lepescheux; Philippe Pujuguet; Line Oste; Nick Vandeghinste; Reginald Brys; Gust Verbruggen; Dirk Elewaut

Introduction Disease severity in collagen-induced arthritis (CIA) is commonly assessed by clinical scoring of paw swelling and histological examination of joints. Although this is an accurate approach, it is also labour-intensive and the application of less invasive and less time-consuming methods is of great interest. However, it is still unclear which of these methods represents the most discriminating measure of disease activity.


Biochemical Journal | 2012

Selection of non-competitive leptin antagonists using a random nanobody-based approach.

Lennart Zabeau; Annick Verhee; Dominiek Catteeuw; Liesbeth Faes; Sylvie Seeuws; Tine Decruy; Dirk Elewaut; Frank Peelman; Jan Tavernier


Rheumatology | 2006

NKT cells: manipulable managers of joint inflammation

Ken Coppieters; Pieter Dewint; K Van Beneden; Peggy Jacques; Sylvie Seeuws; Gust Verbruggen; Dieter Deforce; Dirk Elewaut


Archive | 2011

New insights in the involvement of leptin and NKT cells in autoimmune responses

Sylvie Seeuws


Advances in Experimental Medicine and Biology | 2011

TNF driven activation of invariant NKT cells regulates combined gut and joint inflammation

Peggy Jacques; Sylvie Seeuws; Hamida Hammad; Bart N. Lambrecht; George Kollias; Martine De Vos; Dirk Elewaut


Clinical and Experimental Rheumatology | 2008

Enhanced TNF-driven crosstalk to invariant NKT cells favours regulation of murine spondyloarthritis

Peggy Jacques; Katrien Van Beneden; Sylvie Seeuws; Martine De Vos; Dirk Elewaut

Collaboration


Dive into the Sylvie Seeuws's collaboration.

Top Co-Authors

Avatar

Dirk Elewaut

Ghent University Hospital

View shared research outputs
Top Co-Authors

Avatar

Peggy Jacques

Ghent University Hospital

View shared research outputs
Top Co-Authors

Avatar

Gust Verbruggen

Ghent University Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Martine De Vos

Ghent University Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge